Department of Atomic Energy Tender by Directorate Of Purchase And Stores (GEM/2025/B/6055140)
Lipofectamine CRISPRMAX AS PER ITEM 1 OF ATTACHED SPECIFICATION,Truecut Cas9 protein v2 AS PER ITEM
Tender Timeline
Tender Title: Lipofectamine CRISPRMAX and Truecut Cas9 protein
Tender Reference Number: GEM/2025/B/6055140
Issuing Authority: Department of Atomic Energy
The Department of Atomic Energy invites bids for the supply of essential biochemical products, specifically Lipofectamine CRISPRMAX and Truecut Cas9 protein v2, to fulfill specific scientific and research needs. This tender encompasses the provision of these products as per specified detailed technical requirements and intends to foster high-quality outcomes in various research applications.
Scope of Work and Objectives
The primary objective of this tender is to procure two distinct biochemical products: Lipofectamine CRISPRMAX as outlined in Item 1 of the attached specifications, and Truecut Cas9 protein v2 as specified in Item 2 of the attached specifications. Bidders are expected to deliver these items adhering strictly to the technical specifications provided, ensuring they meet quality standards and performance expectations essential for the intended research applications.
Eligibility Criteria
To be considered eligible for participation in this tender, bidders must meet the following criteria:
- Must be a registered entity with the appropriate business licenses.
- Must possess experience in supplying biochemical products similar to those required.
- Compliance with any pre-qualification criteria specified by the Department of Atomic Energy.
Technical Requirements
The bidders must adhere to the defined technical specifications surrounding the products being requested. This includes:
- Meeting specific quality standards and performance criteria as outlined in the tender documentation.
- Providing certifications that confirm the authenticity and suitability of their products for research implementations.
Financial Requirements
Bidders need to demonstrate their financial credibility to ensure they can meet the contract obligations upon award. This typically involves:
- Providing financial statements for the last few fiscal years.
- Disclosure of any existing financial obligations that may affect tender fulfillment.
Document Submission Details
All documentation must be submitted in accordance with the guidelines outlined in the tender documents. Each submission should include:
- A completed bid form.
- Technical and financial proposals.
- Any additional information requested by the Department of Atomic Energy.
Special Provisions
Bidders are encouraged to review any provisions for Micro, Small, and Medium Enterprises (MSEs) or Startups, which may provide leeway in bidding costs or flexibility in delivery terms.
Evaluation Process
The evaluation of bids will be conducted based on:
- Compliance with the technical specifications.
- Financial viability and offer pricing.
- Overall experience and past performance in similar projects.
Delivery Locations
The delivered products must comply with the delivery specifications outlined in the tender documentation. The bidders should ensure that the delivery locations align with the requirements of the Department of Atomic Energy.
Contact Information
For further inquiries or clarification regarding this tender, bidders should reach out via the contact details provided within the official tender communication from the Department of Atomic Energy.
In summary, this tender aims to secure Lipofectamine CRISPRMAX and Truecut Cas9 protein to support vital research initiatives within the department. All interested and eligible bidders are encouraged to carefully prepare and submit their proposals in accordance with the outlined guidelines.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
5 DocumentsDocuments Required from Seller
- Certificate (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The qualification requirements include being a registered entity, possessing relevant experience in providing biochemical products, and complying with any specific criteria set by the Department of Atomic Energy. Additionally, bidders must submit all required documentation to support their eligibility.
The technical specifications require that both Lipofectamine CRISPRMAX and Truecut Cas9 protein v2 meet rigorous quality standards specific to their intended research applications. Bidders must provide detailed documentation and certifications demonstrating compliance with these specifications to qualify for consideration.
Bidders should submit documentation in PDF format to ensure compatibility and accessibility. All submissions must include the completed bid form alongside the technical and financial proposals to meet the tender requirements comprehensively.
Yes, an Earnest Money Deposit (EMD) is typically required to participate in this tender. Bidders must ensure that the EMD amount is submitted along with their bids as a demonstration of commitment to the bidding process.
Yes, the tender includes provisions that provide benefits to Micro, Small, and Medium Enterprises (MSEs). MSEs may receive concessions related to tender pricing and other facilitation measures that encourage participation from smaller businesses, promoting inclusivity in the procurement process.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders